TY  - JOUR

T1  - Denosumab in Patients with Metastatic Prostate Cancer Previously Treated with Denosumab or Zoledronic Acid: 2-Year Open-Label Extension Phase Results from the Pivotal Phase 3 Study

JO  - Annals of Oncology

PY  - 2012/09/01

AU  - Fizazi K

AU  - Brown JE

AU  - Carducci M

AU  - Shore ND

AU  - Sieber P

AU  - Kueppers F

AU  - Karsh L

AU  - Wei R

AU  - Goessl C

ED  - 

DO  - DOI: 10.1016/s0923-7534(20)33497-9

PB  - Elsevier BV

VL  - 23

SP  - ix309

EP  - ix309

Y2  - 2024/12/21

ER  -